Table 4.
Placebo | Total danicamtiv | |
---|---|---|
Troponin I (ng/mL, ULN = 0.03) | (n = 10) | (n = 30) |
Median baseline | 0.010 | 0.010 |
Median change from baseline (max change) | 0.005 (0.03) | 0.010 (0.87) |
Median peak troponin post dose (max peak) | 0.020 (0.05) | 0.025 (0.88) |
hs‐troponin T a (ng/mL, ULN = 0.014) | (n = 7) | (n = 22) |
Median baseline | 0.023 | 0.015 |
Median change from baseline (max change) | 0.002 (0.005) | 0.005 (0.041) |
Median peak troponin post dose (max peak) | 0.025 (0.032) | 0.020 (0.052) |
hs, high‐sensitivity; ULN, upper limit of normal.
hs‐troponin T assessment added after study had started.